drugset / Trial / NCT01805453

Angiotensin II Receptor Blockers, Steroids and Radiotherapy in Glioblastoma

NCT01805453

RandomizedParallel-groupDouble-blindTreatment

Summary

To assess the efficacy of an Angiotensin-II inhibitor (Losartan) to reduce peritumoral edema in newly diagnosed glioblastoma patients.

Timeline

Start
2013-03-29
Primary completion
2015-01-15
Completion
2017-05-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Losartan Other / unclassified 50 mg

Indications